Optimisation Of Ifn Capture Assay A B Pbmc From Healthy Donors

Optimisation of IFN-γ capture assay. (A, B) PBMC from healthy donors ...
Optimisation of IFN-γ capture assay. (A, B) PBMC from healthy donors ...
Optimisation of IFN-γ capture assay. (A, B) PBMC from healthy donors ...
Optimisation of IFN-γ capture assay. (A, B) PBMC from healthy donors ...
Production of IFN-. PBMC from healthy donors (n 6) were stimulated with ...
Production of IFN-. PBMC from healthy donors (n 6) were stimulated with ...
Levels of IFN-and IL-10 obtained from PBMC from healthy donors ...
Levels of IFN-and IL-10 obtained from PBMC from healthy donors ...
Production of IFN-. PBMC from healthy donors (n 6) were stimulated with ...
Production of IFN-. PBMC from healthy donors (n 6) were stimulated with ...
In vitro cytokine induction assay a Human PBMCs from healthy donors ...
In vitro cytokine induction assay a Human PBMCs from healthy donors ...
In vitro cytokine induction assay a Human PBMCs from healthy donors ...
In vitro cytokine induction assay a Human PBMCs from healthy donors ...
ADCC assay using PBMC from healthy donors or H441 human lung tumor ...
ADCC assay using PBMC from healthy donors or H441 human lung tumor ...
Cytokines in supernatants of PHA‐stimulated PBMC from healthy donors ...
Cytokines in supernatants of PHA‐stimulated PBMC from healthy donors ...
Type I and type III IFN mRNA basal levels in PBMCs from healthy donors ...
Type I and type III IFN mRNA basal levels in PBMCs from healthy donors ...
Induction of IFN-secretion in PBMCs from a healthy donor (donor 1) and ...
Induction of IFN-secretion in PBMCs from a healthy donor (donor 1) and ...
Induction of IFN after infection of PBMCs derived from 10 healthy ...
Induction of IFN after infection of PBMCs derived from 10 healthy ...
Cytokine production. PBMC from normal healthy donors were incubated in ...
Cytokine production. PBMC from normal healthy donors were incubated in ...
Induction of IFN after infection of PBMCs derived from 10 healthy ...
Induction of IFN after infection of PBMCs derived from 10 healthy ...
Experimental overview (A) Isolation of PBMCs from healthy donors and ...
Experimental overview (A) Isolation of PBMCs from healthy donors and ...
A, PBMC from a HLA-DRB1*0301+ healthy donor were primed in vitro with ...
A, PBMC from a HLA-DRB1*0301+ healthy donor were primed in vitro with ...
(A and B) PBMCs isolated from the peripheral blood of 3 healthy donors ...
(A and B) PBMCs isolated from the peripheral blood of 3 healthy donors ...
Type I and type III IFN mRNA basal levels in PBMCs from healthy donors ...
Type I and type III IFN mRNA basal levels in PBMCs from healthy donors ...
Levels of IFN-α secreted by PBMC from healthy (n = 9 to 12) or ...
Levels of IFN-α secreted by PBMC from healthy (n = 9 to 12) or ...
(A and B) PBMCs isolated from the peripheral blood of 3 healthy donors ...
(A and B) PBMCs isolated from the peripheral blood of 3 healthy donors ...
The PBMC compartment has evidence of a type I IFN signature in primary ...
The PBMC compartment has evidence of a type I IFN signature in primary ...
Comparison of IFN- ␣ production in PDC ( a ) and PBMC ( b ) obtained ...
Comparison of IFN- ␣ production in PDC ( a ) and PBMC ( b ) obtained ...
Human PBMC responses to nApa and rApa. (A–E) PBMCs from healthy donors ...
Human PBMC responses to nApa and rApa. (A–E) PBMCs from healthy donors ...
IFN-γ production by PBMCs from healthy donors is reduced by incubation ...
IFN-γ production by PBMCs from healthy donors is reduced by incubation ...
IFN ␣ treatment of PBMCs induces TC-specific deaminase activity. A ...
IFN ␣ treatment of PBMCs induces TC-specific deaminase activity. A ...
Ex-vivo IFN-γ production by PBMCs from healthy donors in response to ...
Ex-vivo IFN-γ production by PBMCs from healthy donors in response to ...
IFN-a response of PBMC from normal donors. Stimulation was performed ...
IFN-a response of PBMC from normal donors. Stimulation was performed ...
a Antigen-specific IFN-γ release of autologous PBMC after coculture ...
a Antigen-specific IFN-γ release of autologous PBMC after coculture ...
Ex-vivo IFN-γ production by PBMCs from healthy donors in response to ...
Ex-vivo IFN-γ production by PBMCs from healthy donors in response to ...
HBsAg diminishes IFN-λ1 production by BDCA3+ DCs. (A) PBMC from healthy ...
HBsAg diminishes IFN-λ1 production by BDCA3+ DCs. (A) PBMC from healthy ...
IFN-γ secretion by PBMC from PPD-, PPD+ and BCG-vaccinated healthy ...
IFN-γ secretion by PBMC from PPD-, PPD+ and BCG-vaccinated healthy ...
(A) Comparison of the ability of healthy donors and CHB patients to ...
(A) Comparison of the ability of healthy donors and CHB patients to ...
(A) PBMCs from healthy donors were incubated with 1000 U/ml ...
(A) PBMCs from healthy donors were incubated with 1000 U/ml ...
Exploring the Potential Use of a PBMC-Based Functional Assay to ...
Exploring the Potential Use of a PBMC-Based Functional Assay to ...
PBMC from 4 healthy CMV pp65 responding donor were stimulated for 8 day ...
PBMC from 4 healthy CMV pp65 responding donor were stimulated for 8 day ...
IFN-γ responses to individual peptides by PBMCs from healthy donors ...
IFN-γ responses to individual peptides by PBMCs from healthy donors ...

Loading image details...

Source
Dimensions